We are live on ! Find out more
EHWM

Eads & Heald Wealth Management Portfolio holdings

AUM $204M
1-Year Est. Return 28.27%
This Fund
S&P 500
This Quarter Est. Return
+13.03%
1 Year Est. Return
+28.27%
3 Year Est. Return
+84.36%
5 Year Est. Return
+119.71%
10 Year Est. Return
+418.2%
AUM
$197M
AUM Growth
+$20.3M
Cap. Flow
-$363K
Cap. Flow %
-0.18%
Top 10 Hldgs %
15.03%
Holding
148
New
5
Increased
49
Reduced
78
Closed
3

Top Sells

Rank Stock Value
1
VRSK icon
Verisk Analytics
VRSK
+$329K
2
CBRE icon
CBRE Group
CBRE
+$300K
3
CRM icon
Salesforce
CRM
+$239K
4
LRCX icon
Lam Research
LRCX
+$238K
5
GPC icon
Genuine Parts
GPC
+$199K

Sector Composition

Rank Sector Weight
1 Healthcare 18.97%
2 Technology 15.68%
3 Industrials 15.57%
4 Consumer Staples 14.39%
5 Consumer Discretionary 12.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPD icon
26
Expeditors International
EXPD
$23.7B
$2.46M 1.25%
23,639
-100
-0.4% -$10.3K
ABBV icon
27
AbbVie
ABBV
$431B
$2.43M 1.24%
15,040
-21
-0.1% -$3.22K
CHD icon
28
Church & Dwight Co
CHD
$24.4B
$2.42M 1.23%
30,000
-45
-0.1% -$3.45K
AXP icon
29
American Express
AXP
$234B
$2.37M 1.21%
16,060
-78
-0.5% -$11.6K
MSFT icon
30
Microsoft
MSFT
$3.66T
$2.35M 1.19%
9,794
+63
+0.6% +$15.1K
BDX icon
31
Becton Dickinson
BDX
$46.9B
$2.33M 1.19%
9,161
+97
+1% +$22.9K
JNJ icon
32
Johnson & Johnson
JNJ
$614B
$2.3M 1.17%
13,012
+432
+3% +$74.6K
NOC icon
33
Northrop Grumman
NOC
$78.4B
$2.27M 1.16%
4,164
-40
-1% -$20.9K
CVS icon
34
CVS Health
CVS
$133B
$2.26M 1.15%
24,215
+1,059
+5% +$102K
CSL icon
35
Carlisle Companies
CSL
$15.3B
$2.19M 1.11%
9,275
-57
-0.6% -$14.7K
BMY icon
36
Bristol-Myers Squibb
BMY
$135B
$2.1M 1.07%
29,260
+3,214
+12% +$242K
CL icon
37
Colgate-Palmolive
CL
$73.8B
$2.08M 1.06%
26,405
-47
-0.2% -$3.52K
NEE icon
38
NextEra Energy
NEE
$182B
$2.07M 1.05%
24,732
+239
+1% +$19.3K
GPC icon
39
Genuine Parts
GPC
$18.3B
$2.06M 1.05%
11,881
-1,145
-9% -$199K
ABT icon
40
Abbott
ABT
$182B
$1.94M 0.98%
17,621
+217
+1% +$22.5K
DLTR icon
41
Dollar Tree
DLTR
$25.1B
$1.93M 0.98%
13,644
-80
-0.6% -$11.9K
SHW icon
42
Sherwin-Williams
SHW
$87.8B
$1.93M 0.98%
8,124
-97
-1% -$22.4K
EW icon
43
Edwards Lifesciences
EW
$51.6B
$1.9M 0.97%
25,489
+1,271
+5% +$98K
CSCO icon
44
Cisco
CSCO
$480B
$1.9M 0.96%
39,791
-335
-0.8% -$15.2K
AMZN icon
45
Amazon
AMZN
$2.99T
$1.89M 0.96%
22,495
+2,215
+11% +$219K
XOM icon
46
ExxonMobil
XOM
$638B
$1.83M 0.93%
16,551
-532
-3% -$57K
FAST icon
47
Fastenal
FAST
$57B
$1.76M 0.9%
74,412
-640
-0.9% -$15.6K
SJM icon
48
J.M. Smucker
SJM
$12.7B
$1.75M 0.89%
11,061
-147
-1% -$21.9K
HON icon
49
Honeywell
HON
$78.9B
$1.75M 0.89%
8,655
-38
-0.4% -$7.26K
DHI icon
50
D.R. Horton
DHI
$42.1B
$1.72M 0.87%
19,238
-55
-0.3% -$4.41K

Similar funds

Eads & Heald Wealth Management's Q4 2022 Portfolio in Review

As of Q4 2022, Eads & Heald Wealth Management held 148 positions worth $197M, up 12% from $176M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Eads & Heald Wealth Management's Q4 2022 filing shows 5 new, 49 increased, 78 reduced and 3 closed positions. Its largest new stake was Charles River Laboratories: 2,851 shares worth $621K. The largest sale was Verisk Analytics, an estimated $329K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

  • Eads & Heald Wealth Management's largest Q4 2022 buy was Charles River Laboratories: 2,851 shares worth $621K.
  • Eads & Heald Wealth Management added most to Crown Holdings in Q4 2022, an estimated $380K increase.
  • Eads & Heald Wealth Management's biggest Q4 2022 reduction was Verisk Analytics, cutting an estimated $329K.
  • Eads & Heald Wealth Management fully exited Cleveland-Cliffs in Q4 2022, selling an estimated $199K.
  • Eads & Heald Wealth Management's ten largest holdings make up 15% of its $197M portfolio in Q4 2022.
  • Eads & Heald Wealth Management opened 5 new positions and closed 3 in Q4 2022.
  • Eads & Heald Wealth Management's portfolio value rose 12% quarter-over-quarter to $197M.

Based on Eads & Heald Wealth Management's 13F filing for Q4 2022, filed 27 Jan 2023.